SOCS-3 is an insulin-induced negative regulator of insulin signaling

Citation
B. Emanuelli et al., SOCS-3 is an insulin-induced negative regulator of insulin signaling, J BIOL CHEM, 275(21), 2000, pp. 15985-15991
Citations number
54
Categorie Soggetti
Biochemistry & Biophysics
Journal title
JOURNAL OF BIOLOGICAL CHEMISTRY
ISSN journal
00219258 → ACNP
Volume
275
Issue
21
Year of publication
2000
Pages
15985 - 15991
Database
ISI
SICI code
0021-9258(20000526)275:21<15985:SIAINR>2.0.ZU;2-0
Abstract
The SOCS proteins are induced by several cytokines and are involved in nega tive feedback loops. Here we demonstrate that in 3T3-L1 adipocytes, insulin , a hormone whose receptor does not belong to the cytokine receptor family, induces SOCS-3 expression but not CIS or SOCS-2, Using transfection of COS -7 cells, we show that insulin induction of SOCS-3 is enhanced upon Stat5B expression. Moreover, Stat5B from insulin-stimulated cells binds directly t o a Stat element present in the SOCS-3 promoter. Once induced, SOCS-3 inhib its insulin activation of Stat5B without modifying the insulin receptor tyr osine kinase activity. Two pieces of evidence suggest that this negative re gulation likely results from competition between SOCS-3 and Stat5B binding to the same insulin receptor motif. First, using a yeast two-hybrid system, we show that SOCS-3 binds to the insulin receptor at phosphotyrosine 960, which is precisely where Stat5B binds. Second, using confocal microscopy, w e show that insulin induces translocation of SOCS-3 from an intracellular c ompartment to the cell membrane, leading to colocalization of SOCS-3 with t he insulin receptor. This colocalization is dependent upon phosphorylation of insulin receptor tyrosine 960, Indeed, in cells expressing an insulin re ceptor mutant ill which tyrosine 960 has been mutated to phenylalanine, ins ulin does not modify the cellular localization of SOCS-3. We have thus reve aled an insulin target gene of which the expression is potentiated upon Sta t5B activation. By inhibiting insulin-stimulated Stat5B, SOCS-3 appears to function as a negative regulator of insulin signaling.